Latest Systemic lupus erythematosus Stories
HAYWARD, Calif., March 12, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc.
Achieve is conducting a phase II, placebo-controlled, multi dose, 24-week clinical study to evaluate the efficacy and safety of a new autoimmune medication in participants living with
The new “Autoimmune Disease Treatment” writing on the website Vkool.com covers natural ways to treat autoimmune diseases effectively. Seattle, Wa (PRWEB)
Lupus Research Organizations Welcome Big-Science Push to Drive New Therapies for Lupus Patients NEW YORK, Feb.
Lupus Foundation of America Joins a Five-Year Initiative to Bring Together Government, Academia, Industry and Nonprofit Health Organizations to Harness Capabilities and Resources
HAYWARD, Calif., Jan. 30, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc.
LOS ANGELES, Jan. 30, 2014 /PRNewswire/ -- Lupus LA and Cedars-Sinai Medical Center have joined together to support a two-year fellowship and have named Dr.
New LIFELINE Grant Will Help Sustain Lupus Research That's at the Brink of Breakthrough WASHINGTON, Jan.
WASHINGTON, Jan. 17, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America applauds Congress for enacting the Consolidated Appropriations Act of 2014, H.R.
Brings Total to $6.6 Million to Educate Healthcare Professionals on Front-Lines of Care NEW YORK, Jan.